FierceBiotech 3 dic 2025 Fierce Biotech Fundraising Tracker '25: Triana glues $120M series B; Protego raises $130M
FierceBiotech 3 dic 2025 With site 'irregularities,' Bristol Myers delays key Cobenfy readout in Alzheimer's psychosis
FierceBiotech 3 dic 2025 Pfizer-backed Triana scores $120M series B to take molecular glue degrader into clinic
FierceBiotech 2 dic 2025 Janux T-cell engager data sink stock, but analysts still see best-in-class potential
FierceBiotech 2 dic 2025 Boston Scientific claims European approval for Farapoint focal pulsed field ablation catheter
FierceBiotech 2 dic 2025 Imvax takes brain cancer cell therapy to FDA, betting survival hit will overshadow primary miss
FierceBiotech 2 dic 2025 Tiziana to spin out IL-6 drug into new company, citing Big Pharma's interest in modality
FierceBiotech 2 dic 2025 Roche's point-of-care whooping cough test greenlighted in US, Europe as cases surge
FierceBiotech 2 dic 2025 FDA adopts agentic AI in latest push to infuse artificial intelligence into agency
FierceBiotech 1 dic 2025 European Union teams up with Angelini to funnel €150M to European health startups